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Background: Among a variety of more common differential diagnoses, the aetiology of acute respiratory failure
includes Lyme neuroborreliosis.
Case presentation: We report an 87-years old huntsman with unilateral phrenic nerve palsy as a consequence of
Lyme neuroborreliosis.
Conclusion: Although Lyme neuroborreliosis is a rare cause of diaphragmatic weakness, it should be considered in
the differential workup because of its potentially treatable nature.
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Lyme neuroborreliosis (LNB) is the neurological manifest-
ation of the systemic infection caused by the spirochete
Borrelia burgdorferi (BB) sensu lato. Clinical features of
LNB are diverse and differ among European and Ameri-
can patients, most probably because of differences in the
distribution of Borrelia species in Europe and North
America [1,2]. The most common neurological manifest-
ation of LNB in European adults is polyradiculoneuritis
(Bannwarth’s syndrome) [3], which typically occurs in
patients older than 50 years, while in younger patients a
meningitic syndrome of LNB is common [4]. Although
several studies indicate that severe paralysis may occur in
LNB [1], diaphragmatic weakness as a symptom of LNB is
rare [2]. Here we report a case of LNB leading to a reduc-
tion of vital capacity and severe dyspnoea as a conse-
quence of unilateral paralysis of the diaphragm.Case presentation
An 87-years old huntsman presented with severe head-
ache, shooting left-sided thoracic pain, fatigue and vertigo.
Neurological examination revealed partial dysfunction of
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reproduction in any medium, provided the ora right facial palsy, with dysarthria and dysphagia as a con-
sequence of facial weakness developed. Although the pa-
tient reported multiple previous tick bites, he had never
noticed an erythema migrans. Brain magnetic resonance
imaging (MRI) without and with contrast medium was
unremarkable. The cerebrospinal fluid (CSF) analysis
revealed a lymphocytic pleocytosis (129 cells/μl), an ele-
vated lactate level of 2,6 mmol/l, a protein level of
1324 mg/l and an intrathecal Borrelia burgdorferi (BB)-
IgG antibodies synthesis (BB-specific antibody index for
IgG 5.0 and for IgM 0.8). BB-PCR of CSF was negative.
The negative CSF PCR for BB-specific DNA does not ex-
clude the diagnosis, as the sensitivity of PCR in LNB is
very low [5].
These findings led to the diagnosis of acute LNB. The
patient was treated with intravenous ceftriaxone at a
dose of 2 g/d for two weeks. His symptoms of headache,
dysarthria and dysphagia improved, facial and abducens
nerve palsies recovered slowly. Two days following his
discharge from hospital, the patient developed dyspnoea
and a mild cough. The clinical diagnosis upon out-patient
review was pneumonia, and the patient was admitted
again. Biplanar chest radiography showed a partial atelec-
tasis of the left lower lobe, and screening fluoroscopy
showed paralysis of the left hemidiaphragm (Figure 1A),
but no air-space shadowing indicative of pneumonia. No
leucocytosis or elevated C-reactive protein were found on
laboratory analysis. Oral antibiotic treatment with doxycy-
clin (200 mg/d) was commenced and continued fortd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Frontal projection screening fluoroscopy images of the patient’s diaphragms during spontaneous ventilation in Lyme
neuroborreliosis. At the time when the patient’s dyspnoea developed (Panel A), there was no significant change in the position and shape of
the left hemidiaphragm between expiration (left) and inspiration (right; arrows). Six months following treatment (Panel B), there was relative
depression and, specifically, flattening of the left hemidiaphragm on inspiration (right as compared to left image; arrows). Note relative splinting
of the left hemidiaphragm due to gaseous distension of the gastric fundus (all images).
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the diaphragmatic weakness. During the following two
weeks dyspnoea did, however, not resolve. Pulmonary
function tests revealed a vital capacity of 2.6 l. To exclude
a mass lesion of the lung, chest computerised tomography
(CT) was done. It confirmed elevation of the left hemi-
diaphragm and partial atelectasis of the left lower lobe,
associated with a small pleural effusion without detection
of other lung lesions. Bronchoscopy was unremarkable, so
that no other cause for the paralysis was found. Diaphrag-
matic paralysis in our patient became first evident after
the presentation with typical clinical neurological features
of acute LNB and CSF findings indicating a recent infec-
tion with BB.
Six months later, the patient had no dyspnoea at rest
but continued to be short of breath on exertion. Repeat
fluoroscopic examination showed partial recovery of the
diaphragmatic weakness (Figure 1B). The abducens
nerve palsy had recovered completely, but a mild facial
palsy remained.
Lyme borreliosis may involve all parts of the nervous
system [1] with as many as 15–20% of infected patients
developing neurological symptoms [6]. These usually
occur in the first three months following the infection.
Diaphragmatic weakness has been associated with trauma,
malignant compression or infiltration, metabolic, inflam-
matory and other disorders, but rarely with Lyme disease
[7]. Early recognition and appropriate treatment of dia-
phragmatic paralysis caused by BB is important in
order to shorten the duration of severe respiratory
symptoms [7].
Unilateral diaphragmatic paralysis is a respiratory dis-
order, and many neurological diseases, such as spinal
cord injury, motor neuron disease, and carcinomatous
infiltration of the phrenic nerve are included in its differ-
ential diagnosis [8]. The development of respiratory com-
promise due to peripheral nerve involvement in patients
with LNB is rare. To our knowledge, only 8 such patients
have been described in the literature [7,9-13]. The severity
of the respiratory involvement varies from mild symptomsto the need for artificial ventilation for several months
[7,13]. In the last published report, as many as three
patients with diaphragmatic weakness caused by LNB pre-
sented over a one-year period. This suggests that the inci-
dence of LNB as a cause of diaphragmatic weakness is
underestimated [13].
Diaphragmatic weakness in LNB results from radiculo-
pathy of the nerve roots C3-C5 or neuropathy of the
phrenic nerve [13]. The pathogenesis of the nervous sys-
tem involvement is uncertain: both direct infection with
stimulation of Toll-like receptors [14] as well as im-
munological mechanisms with stimulation of T- and B-
cells [15] may play a role.
As in the present case, the clinical diagnosis of LNB is
based on a combination of history, typical clinical symp-
toms, the detection of BB antibodies in serum and CSF
and calculation of the BB-specific antibody index [4]. BB
antibody tests in serum may be negative in early infec-
tion. Conversely, serum antibodies against BB are detect-
able in up to 25% of healthy persons in Europe [16]. In
some patients, antibodies against BB may be detect-
able in CSF slightly earlier than in serum [4]. Both BB-
specific antibodies in serum and BB-specific intra-
thecal antibody synthesis can persist for years after
eradication of the infection [17]. In recent years, the B
lymphocyte chemoattractant chemokine CXCL13 has
been identified as a potentially important biomarker
for the diagnosis of acute LNB [18,19]. CXCL13, however,
seems to be the major determinant for B cell recruitment
to the CNS compartments in different neuroinflammatory
diseases and not just in LNB [20]. CXCL13 levels in the
CSF rather reflect a strong humoral immune response in
the CNS compartments than being specific for a particular
disease entity [20].
The marked inflammatory response in CSF (lympho-
pleocytosis and production of BB-specific antibodies and
the absence of other causes) indicate an acute Lyme neu-
roborreliosis as the reason for respiratory failure in the
present case. Irrespective of appropriate antibiotic therapy,
diaphragmatic dysfunction in our patient persisted for a
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mens is usually effective in LNB [21] but some symptoms
may persist longer despite antibiotic treatment, and the
recovery can be incomplete [22-24].
Conclusion
LNB should be considered in the differential diagnosis
of acute respiratory failure due to diaphragmatic paraly-
sis since it requires adequate antibiotic treatment. It is
important in clinical practice to consider Lyme neuro-
borreliosis also in patients presenting with respiratory
failure as an isolated syndrome.
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